Qualitative and quantitative changes in skin T cells during treatments of skin disorders

Qualitative and quantitative changes in skin T cells during treatments of skin disorders - Skin disorders and skin T cells

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027423

Enrollment

Registered

2017-06-01

Start date

2017-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory skin disorders, allergic skin disorders, collagen disease

Interventions

To collect skin biopsy specimens and blood samples after skin lesion is cleared by any kinds of treatments

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The skin disorder patients whose skin lesions disappeared after any kinds of treatments and who underwent skin biopsies for the sake of diagnosis before treatments.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Percentages of CCR7+CD62L+ central memory T cells, CCR7+CD62L- migratory memory T cells and CD69+CD103+ resident memory T cells in total T cells in lesional skin, non-lesional skin and blood before and after treatments.	—

Countries

Japan

Contacts

Public ContactRei Watanabe

University of Tsukuba Division of Medicine, Department of Dermatology

rwatanabe@md.tsukuba.ac.jp029-853-3128

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026